Hacker News Reader

> The drug is based on a molecule he discovered while working at Pfizer

I can see Pfizer lawyers salivating uncontrollably after reading that phrase. Extremely unwise of him to mention this.

Until they read the next part:

> On leaving the company, he acquired the intellectual property [IP] rights from his former employer

And Pfizer is an investor in his company.